Phibro Animal Health Corp expected to post earnings of 25 cents a share - Earnings Preview

Phibro Animal Health

04/11/2024 23:45

* Phibro Animal Health Corp  PAHC.OQ   PAHC.O  is expected
to show
a rise in quarterly revenue when it reports  results on November
6 for the period ending September 30 2024
    * The Teaneck New Jersey-based  company is expected to
report a
5.6% increase in revenue to $244.4 million from $231.35 million
a year ago, according to the mean estimate from 3 analysts,
based on LSEG data.
    * ​LSEG's mean analyst estimate for Phibro Animal Health
Corp is
for earnings of 25 cents per share. 
    * The current average analyst rating on the shares is "sell"
and
the breakdown of recommendations is no "strong buy" or "buy," 2
"hold" and 3 "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Phibro
Animal
Health Corp is 19.00​, below​ its last closing price of $22.37.
​​​

Previous quarterly performance (using preferred earnings measure
in US dollars). ​
 QUARTER       STARMINESM  LSEG IBES  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  ESTIMATE             MET,    SE %
               E®                               MISSED  
 Jun. 30 2024  0.33        0.33       0.41      Beat    23
 Mar. 31 2024  0.29        0.29       0.31      Beat    6.9
 Dec. 31 2023  0.29        0.28       0.33      Beat    18​
 Jan. 1 0001   0.23        0.23       0.14      Missed  -39.1
 ​​Jun.        0.39        0.38       0.38      Met     -1.1
 30 2023                                                
 Mar. 31 2023  0.33        0.34       0.29      Missed  -13.4​
 Jan. 1 0001   0.30        0.30       0.34      Beat    12.2
 Sep. 30 2022  0.27        0.27       0.21      Missed  -20.9
 This summary was machine generated November 4 at 23:45 GMT.  All
figures in US dollars unless otherwise stated. (For questions
concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com)